Influence of atorvastatin to high sensitive C-reactive protein in the new onset type 2 diabetes of normal blood lipid with macrovascular disease
10.3760/cma.j.issn.1008-6706.2009.01.036
- VernacularTitle:阿托伐他汀对血脂正常的初诊2型糖尿病并发大血管病变患者超敏C反应蛋白的影响
- Author:
Zhaohui HU
;
Jiahe IDU
;
Dongjuan HE
;
Jinxing WAN
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus,type 2;
Atorvastatin;
C-reactive protein;
Macroangiopathy
- From:
Chinese Journal of Primary Medicine and Pharmacy
2009;16(1):67-68
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe influence of atorvastatin to high sensitive C-reactlve protein in the new on-set type 2 diabetes of normal blood lipid with macrovascular disease. Methods 96 cases with the new onset type 2 diabetes of normal blood lipid with macrovascu]ar disease were randomly divided into two groups,the treatment group contains 49 cases who were given atorvastatin 10rag for 12 weeks,the control group contains 47 cases who were given placebo for 12 weeks. Two groups were underwent the following test,fasting plasma glucose(FBG) ,post-OGTT 2 hour plasma glucose(PPG) ,glycosy-lated hemoglobin(HbAic) ,total triglyceride(TG) ,total cholesterol(TC) ,low density lipoprotein cholesterol(LDL-C) ,high sensitive C-reactive protein(hs-CRP). Results High sensitive C-reactive pro-tein(hs-CRP) in treatment group is significantly lower than control group[(2.13±1.38) mg/L and (4.04±3.14) mg/L,P < 0.05]. Conclusion Atorvastatin can significantly decease the level of high sensitive C-reactive protein (hs-CRP) to the new onset type 2 diabetes of normal blood lipid with macrovascular disease.
